The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)
Public ClinicalTrials.gov record NCT01106677. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo and Active-Controlled, 4-Arm, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of canagliflozin compared with sitagliptin and placebo in patients with type 2 diabetes mellitus who are receiving treatment with metformin monotherapy (i.e., treatment with a single drug) and have inadequate glycemic (blood sugar) control.
Study identification
- NCT ID
- NCT01106677
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,284 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Canagliflozin Drug
- Sitagliptin Drug
- Metformin immediate release Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2010 (Type not available)
- Primary completion
- Oct 2011 (Actual)
- Completion
- May 2012 (Actual)
- Last update posted
- Jul 30, 2013
2010 – 2012
United States locations
- U.S. sites
- 45
- U.S. states
- 27
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Fountain Valley | California | — | — |
| Not listed | National City | California | — | — |
| Not listed | Northridge | California | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Bradenton | Florida | — | — |
| Not listed | Brooksville | Florida | — | — |
| Not listed | DeFuniak Springs | Florida | — | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Niceville | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Savannah | Georgia | — | — |
| Not listed | Champaign | Illinois | — | — |
| Not listed | Avon | Indiana | — | — |
| Not listed | Fishers | Indiana | — | — |
| Not listed | Franklin | Indiana | — | — |
| Not listed | West Des Moines | Iowa | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Munfordville | Kentucky | — | — |
| Not listed | Portland | Maine | — | — |
| Not listed | Benzonia | Michigan | — | — |
| Not listed | Interlochen | Michigan | — | — |
| Not listed | Troy | Michigan | — | — |
| Not listed | Picayune | Mississippi | — | — |
| Not listed | Florissant | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Mansfield | New Jersey | — | — |
| Not listed | New Hyde Park | New York | — | — |
| Not listed | Asheboro | North Carolina | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Kettering | Ohio | — | — |
| Not listed | Oregon City | Oregon | — | — |
| Not listed | Altoona | Pennsylvania | — | — |
| Not listed | Tipton | Pennsylvania | — | — |
| Not listed | East Providence | Rhode Island | — | — |
| Not listed | Greer | South Carolina | — | — |
| Not listed | Mt. Pleasant | South Carolina | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | New Braunfels | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Bountiful | Utah | — | — |
| Not listed | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 80 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01106677, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2013 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01106677 live on ClinicalTrials.gov.